IVAInventiva S.A.
4.680USDMkt Cap: 1.11B $P/E: —3d ago
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in F…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap1.11B $
Enterprise Value1.12B $
Revenue (TTM)6.76M $
Gross Profit6.74M $
Net Income (TTM)-354.14M $
Revenue/Share0.0360 USD
Last Price4.680 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees69
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINFR0013233012
Valuation
P/E (Trailing)—
P/E (Forward)-5.58
PEG—
EV/EBITDA-8.45
EV/Revenue165.62
P/S162.47
P/B-27.16
EPS (TTM)-2.20
EPS (Forward)-0.83
52W Range
4.64526% of range4.780
52W High4.780 USD
52W Low4.645 USD
Profitability
Gross Margin99.68%
Oper. Margin-6710.69%
EBITDA Margin0.00%
Profit Margin-7899.58%
ROE1241.63%
ROA-141.93%
Growth
Revenue Growth-89.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-104.88M $
CapEx (TTM)247.00K $
FCF Margin-2968.67%
FCF Yield-18.16%
Net Debt131.05M $
Net Debt/EBITDA-0.99
Balance Sheet
Debt/Equity-2.10
Current Ratio3.16
Quick Ratio1.41
Book Value/Sh-0.1712 USD
Cash/Share0.4810 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)14.88 USD
Upside (mean)+218.0%
Target Range8.800 USD – 26.00 USD
$8.800+218.0% to mean$26.00
# Analysts13
Ownership
Shares Out.236.22M
Float157.92M
Insiders0.00%
Institutions41.80%
Short Interest
Short Ratio1.6d
Short % Float0.98%
Short % Out.0.93%
Shares Short2.20M
Short (prev mo.)1.42M
Technical
SMA 504.240 (+10.4%)
SMA 2005.028 (-6.9%)
Beta0.91
S&P 52W Chg21.00%
Avg Vol (30d)461.30K
Avg Vol (10d)519.04K
Technical Indicators
RSI (14)54.3
MACD0.0812
MACD Signal0.0929
MACD Hist.-0.0116
BB Upper4.874 USD
BB Middle4.628 USD
BB Lower4.383 USD
BB Width10.61%
ATR (14)0.2078 USD
Vol Ratio (20d)0.66x